Bromodomain and extra-terminal motif proteins regulate linear and circular pvt1 in acute myeloid leukemia cells under normoxi and hypoxia

Bromodomain and extra-terminal motif proteins regulate linear and circular pvt1 in acute myeloid leukemia cells under normoxi and hypoxia

INTRODUCTION: Bromodomain and extra-terminal motif-protein inhibitors (BETi) have shown an antileukemic effect in several subtypes of acute myeloid leukemia (AML), both in vitro and in vivo (Daniel Gerlach et al. 2018 Oncogene). The effect of BETi is mainly mediated by suppression of bromodomain-con...

Full description

Bibliographic Details
Main Authors:	M. Ghetti, I. Vannini, S. Bruno, C. Liverani, D. Traversa, L. Montanaro, R. Napolitano, A. Ghelli Luserna di Rorà, T. Ibrahim, C.T. Storlazzi, G. Martinelli, G. Simonetti
Format:	Article
Language:	English
Published:	MDPI AG 2020-09-01
Series:	Hematology Reports
Online Access:	https://www.pagepress.org/journals/index.php/hr/article/view/8909

Similar Items

Uncovering the expression of circPVT1 in the extracellular vesicles of acute myeloid leukemia patients
by: Martina Ghetti, et al.
Published: (2023-09-01)

Targeting Proliferation Signals and the Cell Cycle Machinery in Acute Leukemias: Novel Molecules on the Horizon
by: Andrea Ghelli Luserna di Rorà, et al.
Published: (2023-01-01)

77232 The role of the bromodomain and extra-terminal motif (BET) family of proteins in head and neck cancer tumorigenic phenotype
by: Reilly A. Sample, et al.
Published: (2021-03-01)

Venetoclax durable response in adult relapsed/refractory Philadelphia-negative acute lymphoblastic leukemia with JAK/STAT pathway alterations
by: Anna Ferrari, et al.
Published: (2023-05-01)

Roles of Bromodomain Extra Terminal Proteins in Metabolic Signaling and Diseases
by: Dayu Wu, et al.
Published: (2022-08-01)

Axitinib in Ponatinib-Resistant B-Cell Acute Lymphoblastic Leukemia Harboring a T315L Mutation
by: Valentina Giudice, et al.
Published: (2020-12-01)

Bioactivation of Isoxazole-Containing Bromodomain and Extra-Terminal Domain (BET) Inhibitors
by: Noah R. Flynn, et al.
Published: (2021-06-01)

Bromodomain and Extra-Terminal Protein Inhibitors: Biologic Insights and Therapeutic Potential in Pediatric Brain Tumors
by: Andrew Groves, et al.
Published: (2022-05-01)

Synthesis of Novel Tryptamine Derivatives and Their Biological Activity as Antitumor Agents
by: Giorgia Simonetti, et al.
Published: (2021-01-01)

Therapeutic Potential of Bromodomain and Extra-Terminal Domain Inhibitors for Synovial Sarcoma Cells
by: Yuki Kotani, et al.
Published: (2024-03-01)

Bromodomain and Extra-Terminal (BET) Domain Protein Inhibitors for Solid Tumor Cancers
by: Martin V. Nguyen, et al.
Published: (2020-02-01)

Synergism Through WEE1 and CHK1 Inhibition in Acute Lymphoblastic Leukemia
by: Andrea Ghelli Luserna Di Rorà, et al.
Published: (2019-10-01)

Epigenetic blockade of neoplastic transformation by bromodomain and extra-terminal (BET) domain protein inhibitor JQ-1
by: Zhang, C, et al.
Published: (2016)

Bromodomain and Extra-Terminal Proteins in Brain Physiology and Pathology: BET-ing on Epigenetic Regulation
by: Noemi Martella, et al.
Published: (2023-03-01)

Molecular Dynamic Simulations of Bromodomain and Extra-Terminal Protein 4 Bonded to Potent Inhibitors
by: Siao Chen, et al.
Published: (2021-12-01)

Regulation of inflammatory genes in decidual cells: Involvement of the bromodomain and extra-terminal family proteins.
by: Sandeep Ajgaonkar, et al.
Published: (2023-01-01)

Targeting bromodomain and extra-terminal proteins to inhibit neuroblastoma tumorigenesis through regulating MYCN
by: Xiyao Shi, et al.
Published: (2022-09-01)

Long Noncoding RNA <i>PVT1</i> Is Regulated by Bromodomain Protein BRD4 in Multiple Myeloma and Is Associated with Disease Progression
by: Hiroshi Handa, et al.
Published: (2020-09-01)

Therapeutic Targeting of Acute Myeloid Leukemia by Gemtuzumab Ozogamicin
by: Michele Gottardi, et al.
Published: (2021-09-01)

Noncoding RNA PVT1 in osteosarcoma: The roles of lncRNA PVT1 and circPVT1
by: Tingrui Wu, et al.
Published: (2022-11-01)

Hydrophobic Waters in Bromodomains
by: Serena G. Piticchio, et al.
Published: (2019-08-01)

Selective targeting of bromodomains of the bromodomain-PHD fingers family impairs osteoclast differentiation
by: Meier, JC, et al.
Published: (2017)

Pharmacological Inhibition of WIP1 Sensitizes Acute Myeloid Leukemia Cells to the MDM2 Inhibitor Nutlin-3a
by: Maria Chiara Fontana, et al.
Published: (2021-04-01)

Identification of a chemical probe for bromo and extra C-terminal bromodomain inhibition through optimization of a fragment-derived hit.
by: Fish, P, et al.
Published: (2012)

BET bromodomain ligands: Probing the WPF shelf to improve BRD4 bromodomain affinity and metabolic stability
by: Jennings, L, et al.
Published: (2018)

The bromodomain interaction module.
by: Filippakopoulos, P, et al.
Published: (2012)

The bromodomain interaction module
by: Filippakopoulos, P, et al.
Published: (2012)

Bromodomains as therapeutic targets.
by: Muller, S, et al.
Published: (2011)

First-in-human phase I study of the bromodomain and extraterminal motif inhibitor BAY 1238097: emerging pharmacokinetic/pharmacodynamic relationship and early termination due to unexpected toxicity
by: Postel-Vinay, S, et al.
Published: (2019)

Selective inhibition of BET bromodomains.
by: Filippakopoulos, P, et al.
Published: (2010)

Selective inhibition of BET bromodomains.
by: Filippakopoulos, P, et al.
Published: (2010)

A Comparative Investigation on Solar PVT- and PVT-PCM-Based Collector Constancy Performance
by: MD Shouquat Hossain, et al.
Published: (2023-02-01)

Functional Roles of Bromodomain Proteins in Cancer
by: Samuel P. Boyson, et al.
Published: (2021-07-01)

Functional networks of the human bromodomain-containing proteins
by: Cong Gao, et al.
Published: (2022-08-01)

Developing chemical probes for the BET bromodomains
by: Hewings, D, et al.
Published: (2012)

Targeting bromodomain-containing protein 4 (BRD4) inhibits MYC expression in colorectal cancer cells
by: C. Otto, et al.
Published: (2019-11-01)

Chemical probes for bromodomains outside the BET family
by: Brennan, P, et al.
Published: (2013)

Spotlight on Plant Bromodomain Proteins
by: Eirini Bardani, et al.
Published: (2023-08-01)

Engineered bromodomains to explore the acetylproteome
by: Del Rosario, Amanda M, et al.
Published: (2016)

Targeting low-druggability bromodomains: fragment based screening and inhibitor design against the BAZ2B bromodomain.
by: Ferguson, F, et al.
Published: (2013)